| Literature DB >> 6785258 |
P Imbach, S Barandun, C Baumgartner, A Hirt, F Hofer, H P Wagner.
Abstract
A new immunoglobulin (Ig) for intravenous use was given in high doses to 4 children with refractory idiopathic thrombocytopenic purpura (ITP) and 2 children with idiopathic aplastic anemia (IAA). Within 5-10 days after initiation of Ig therapy the platelets of the children with ITP rose to 300,000-650,000/mm3 and could be maintained at normal levels with one Ig infusion every 1-3 weeks. No reaction was observed in the 2 patients with IAA.Entities:
Mesh：
Substances：
Year: 1981 PMID： 6785258
Source DB: PubMed Journal: Helv Paediatr Acta ISSN： 0018-022X